MedPath

Minster Research Ltd

Ownership
Private
Employees
-
Market Cap
-
Website

Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache

Phase 2
Completed
Conditions
Migraine Without Aura
Migraine With Aura
Interventions
Drug: Placebo
First Posted Date
2007-09-26
Last Posted Date
2009-03-31
Lead Sponsor
Minster Research Ltd
Target Recruit Count
542
Registration Number
NCT00534560

Tonabersat in the Prophylaxis of Migraine With Aura

Phase 2
Completed
Conditions
Migraine With Aura
Interventions
Drug: Placebo
First Posted Date
2006-05-31
Last Posted Date
2009-08-31
Lead Sponsor
Minster Research Ltd
Target Recruit Count
39
Registration Number
NCT00332007
Locations
🇩🇰

Danish Headache Centre, Department of Neurology, Glostrup Hospital, Copenhagen, Denmark

Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache

Phase 2
Completed
Conditions
Migraine Without Aura
Migraine With Aura
Interventions
Drug: Placebo
First Posted Date
2006-04-06
Last Posted Date
2009-08-31
Lead Sponsor
Minster Research Ltd
Target Recruit Count
124
Registration Number
NCT00311662
Locations
🇿🇦

Dr J Bouwer, Pretoria, South Africa

🇭🇺

Borsod Abauj Zemplén Megyei Kórház, Neurologiai Osztaly, Miskolc, Hungary

🇭🇺

Petz Aladár Megyei Oktató Kórház, Gyor, Hungary

and more 14 locations
© Copyright 2025. All Rights Reserved by MedPath